前列腺影像报告和数据系统第2版能否充分发现临床显著前列腺癌?基于病灶的放射-病理对照研究
该回顾性研究纳入44例根治性前列腺切除患者的93个前列腺癌病灶,由两名放射科医生按PI-RADSv2对多参数MRI可见病灶评分3、4或5分,并与病理结果进行病灶一一对照。以PI-RADSv2评分3、4或5分作为MRI可见病灶,检出46.88%的临床显著前列腺癌病灶,阳性预测值96.77%、阴性预测值45.16%、AUC 0.72。结论认为多参数MRI联合PI-RADSv2在基于病灶的分析中遗漏了相当数量的临床显著前列腺癌病灶,导致阴性预测值和诊断性能较既往基于患者的研究偏低,但高阳性预测值提示其可能有助于主动监测随访和局灶治疗规划。
要点
- 以PI-RADSv2评分3、4或5分为MRI可见病灶,临床显著前列腺癌病灶检出率为46.88%。
- 阳性预测值96.77%、阴性预测值45.16%、AUC 0.72。
- 肿瘤体积和次要Gleason分级在MRI可见与不可见的临床显著前列腺癌间差异有统计学意义。
核心结论
- 多参数MRI联合PI-RADSv2在基于病灶的分析中遗漏了相当数量的临床显著前列腺癌病灶,阴性预测值45.16%和AUC 0.72相对既往基于患者的研究偏低,但阳性预测值96.77%较高,可能有助于主动监测随访和局灶治疗规划。
研究设计与样本
- 回顾性研究,纳入44例接受根治性前列腺切除术患者的93个前列腺癌病灶,由两名放射科医生按PI-RADSv2对每个多参数MRI可见病灶评分3、4或5分,并在本中心常规放射-病理会议上进行MRI可见病灶与病理确诊前列腺癌病灶的一一对照。
诊断标准与关键数值
- 以PI-RADSv2评分3、4或5分作为MRI可见病灶,对临床显著前列腺癌的检出率为46.88%,阳性预测值96.77%,阴性预测值45.16%,AUC为0.72。
临床应用与阅片要点
- 作者认为多参数MRI联合PI-RADSv2的高阳性预测值(96.77%)可能有助于主动监测随访和局灶治疗规划。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of our study was to evaluate the performance of multiparametric MRI with Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) for detecting prostate cancer (PCA) and clinically significant PCA through this per-lesion one-to-one correlation study between pathologically proven lesions and MRI-visible lesions.
MATERIALS AND METHODS: A total of 93 PCA lesions from 44 patients who underwent radical prostatectomy were included in this retrospective study. Two radiologists scored every visible lesion with a PI-RADSv2 score of 3, 4, or 5 in each patient's multiparametric MRI examination using PI-RADSv2. A per-lesion one-to-one correlation between MRI-visible lesions and pathologically confirmed PCA lesions was conducted during regular radiology-pathology meetings at our center. The detection rates of clinically significant PCA and the proportions of clinically significant PCAs from MRI-visible and MRI-invisible PCAs were calculated. The performance of PI-RADSv2 for detecting clinically significant PCA was evaluated using the positive predictive value (PPV), negative predictive value (NPV), and area under the ROC curve (AUC) value.
RESULTS: Using a PI-RADSv2 score of 3, 4, or 5 as an MRI-visible lesion, 46.88% of clinically significant PCA lesions were detected. The PPV, NPV, and AUC were 96.77%, 45.16%, and 0.72, respectively. Tumor volume and secondary Gleason grade showed a statistically significant difference between MRI-visible and MRI-invisible clinically significant PCAs.
CONCLUSION: Multiparametric MRI with PI-RADSv2 missed a considerable number of clinically significant PCA lesions in this per-lesion analysis, causing a relatively low NPV and diagnostic performance compared with previous per-patient studies. However, the high PPV indicates that multiparametric MRI with PI-RADSv2 may be useful for follow-up of active surveillance and planning focal therapy.
引用
- Lee MS, Moon MH, Kim YA, et al. Is Prostate Imaging Reporting and Data System Version 2 Sufficiently Discovering Clinically Significant Prostate Cancer? Per-Lesion Radiology-Pathology Correlation Study. AJR Am J Roentgenol. 2018. PMID: 29702017. doi:10.2214/AJR.17.18684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。